StonvexLoading…
StonvexStonvexStonvexCore line items from GIL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $3.62B | $3.27B | $3.20B | $3.24B |
Operating Income | $619.94M | $618.24M | $643.85M | $603.38M |
Net Income | $398.88M | $400.87M | $533.58M | $541.54M |
EPS (Diluted) | $2.61 | $2.46 | $3.03 | $2.93 |
Total Assets | $10.47B | $3.72B | $3.51B | $3.44B |
Total Liabilities | $6.90B | $2.26B | $1.56B | $1.56B |
Cash & Equivalents | $284.46M | $98.80M | $89.64M | $150.42M |
Free Cash Flow OCF − CapEx | $499.88M | $356.06M | $343.32M | $174.36M |
Shares Outstanding | 185.15M | 152.41M | 169.99M | 179.71M |